ICD-10-CM › G00-G99 › G10-G14 › G13 Systemic atrophies primarily... › G13.2
G13.2
Systemic atrophy primarily affecting the central nervous system in myxedema
ValidICD-10-CM diagnosis code.
Valid for claims with a date of service in the current code year.
What has happened to this code
Every change the publisher made, from 2012 to now. Entries marked draft are from the pre-implementation releases: ICD-10 took effect on 1 October 2015, so nothing before FY2016 was ever valid on a claim.
- FY2012 Added to the draft code set draft Systemic atrophy primarily affecting the central nervous system in myxedema
How CDC's index refers to this code
Wording from the official alphabetic index. Much of it appears nowhere in the code description, which is why a search for the everyday phrase so often finds nothing.
- Sclerosis, sclerotic > choroid
- Disorder > choroid > degeneration
- Ataxia, ataxy, ataxic > heredofamilial
- Ataxia, ataxy, ataxic > family, familial
- Degeneration, degenerative > chorioretinal
- Degeneration, degenerative > Bruch's membrane
- Ataxia, ataxy, ataxic > cerebellar > in > myxedema
- Atrophy, atrophic > systemic affecting central nervous system > in > myxedema
Codes in the same group
| Code | Description | Status |
|---|---|---|
| G13.0 | Paraneoplastic neuromyopathy and neuropathy | Valid |
| G13.1 | Other systemic atrophy primarily affecting central nervous system in neoplastic disease | Valid |
| G13.8 | Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere | Valid |